Home  

Random  

Nearby  



Log in  



Settings  



Donate  



About Wikipedia  

Disclaimers  



Wikipedia





Pretibial myxedema





Article  

Talk  



Language  

Watch  

Edit  





Pretibial myxedema (myxoedema in British English, also known as Graves' dermopathy, thyroid dermopathy,[1] Jadassohn-Dösseker diseaseormyxoedema tuberosum) is an infiltrative dermopathy, resulting as a rare complication of Graves' disease,[2] with an incidence rate of about 1–5%.

Pretibial myxedema
Hands showing related condition thyroid acropachy and shins of someone with pretibial myxedema
SpecialtyEndocrinology Edit this on Wikidata

Signs and symptoms

edit

Pretibial myxedema is almost always preceded by the ocular signs found in Graves' disease.[3] It usually presents itself as a waxy, discolored induration of the skin—classically described as having a so-called peau d'orange (orange peel) appearance—on the anterior aspect of the lower legs, spreading to the dorsum of the feet, or as a non-localised, non-pitting edema of the skin in the same areas.[4] In advanced cases, this may extend to the upper trunk (torso), upper extremities, face, neck, back, chest and ears.

The lesions are known to resolve very slowly. Application of petroleum jelly on the affected area could relieve the burning sensation and the itching. It occasionally occurs in non-thyrotoxic Graves' disease, Hashimoto's thyroiditis, and stasis dermatitis. The serum contains circulating factors which stimulate fibroblasts to increase synthesisofglycosaminoglycans.

Risk factors

edit

There are suggestions in the medical literature that treatment with radioactive iodine for Graves' hyperthyroidism may be a trigger for pretibial myxedema[5] which would be consistent with radioiodine ablation causing or aggravating ophthalmopathy, a condition which commonly occurs with pretibial myxedema and is believed to have common underlying features.[6]

Other known triggers for ophthalmopathy include thyroid hormone imbalance, and tobacco smoking, but there has been little research attempting to confirm these are also risk factors for pretibial myxedema.

Diagnosis

edit

Abiopsy of the affected skin reveals mucin in the mid- to lower- dermis. There is no increase in fibroblasts. Over time, secondary hyperkeratosis may occur, which may become verruciform. Many of these patients may also have co-existing stasis dermatitis. Elastic stains will reveal a reduction in elastic tissue.

Management

edit

Many cases of pretibial myxedema, particularly cases that are mild, can be managed without specific pharmacologic treatment; approximately 50% of mild cases achieve complete remission without treatment after several years. When pharmacologic treatment is considered, topical, locally injected, or systemic corticosteroids may be used.[7]

References

edit
  1. ^ Schwartz, K. M.; Vahab Fatourechi; Debra D. F. Ahmed; Gregory R. Pond (1 February 2002). "Dermopathy of Graves' Disease (Pretibial Myxedema): Long-Term Outcome". Journal of Clinical Endocrinology & Metabolism. 87 (2): 438–446. doi:10.1210/jcem.87.2.8220. PMID 11836263.
  • ^ Prajapati VH, Mydlarski PR (March 2008). "Dermacase. Pretibial myxedema". Can Fam Physician. 54 (3): 357, 369. PMC 2278349. PMID 18337527.
  • ^ Dennis, Mark; Bowen, William Talbot; Cho, Lucy (2012). "Pre-tibial myxoedema (thyroid dermopathy)". Mechanisms of Clinical Signs. Elsevier. p. 550. ISBN 978-0729540759; pbk{{cite book}}: CS1 maint: postscript (link)
  • ^ Rongioletti F, Rebora A (2007). "Mucinoses". In Bolognia JL (ed.). Dermatology. St. Louis: Mosby. pp. 616–7. ISBN 978-1-4160-2999-1.
  • ^ Harvey, R. D.; Metcalfe, R. A.; Morteo, C.; Furmaniak, W.; Weetman, A. P.; Bevan, J. S. (1 June 1995). "Acute pre-tibial myxoedema following radioiodine therapy for thyrotoxic Graves' disease". Clinical Endocrinology. 42 (6): 657–660. doi:10.1111/j.1365-2265.1995.tb02695.x. PMID 7634509. S2CID 36798692.
  • ^ PEACEY, S.R.; FLEMMING, L.; MESSENGER, A.; WEETMAN, A.P. (1 February 1996). "Is Graves' Dermopathy a Generalized Disorder?". Thyroid. 6 (1): 41–45. doi:10.1089/thy.1996.6.41. PMID 8777383.
  • ^ Fatourechi V (2005). "Pretibial myxedema: pathophysiology and treatment options". Am J Clin Dermatol. 6 (5): 295–309. doi:10.2165/00128071-200506050-00003. PMID 16252929. S2CID 23661734.
  • edit

    Retrieved from "https://en.wikipedia.org/w/index.php?title=Pretibial_myxedema&oldid=1194531632"
     



    Last edited on 9 January 2024, at 12:58  





    Languages

     


    العربية
    Español
    فارسی
    Français
    Italiano

    Svenska
     

    Wikipedia


    This page was last edited on 9 January 2024, at 12:58 (UTC).

    Content is available under CC BY-SA 4.0 unless otherwise noted.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Terms of Use

    Desktop